Search Results 3041-3050 of 40465 for Two-phase

  1. Efficacy and Safety of Tislelizumab in Combination With Fruquintinib in Participants With Selected Solid Tumors - Mayo Clinic

    Study phase. 1/2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase ( ...

  2. Valproic acid (oral route) - Side effects & dosage - Mayo Clinic

    Valproic acid is also used to treat the manic phase ... Because of valproic acid's toxicity, use in children younger than 2 ... Although certain medicines should ...

  3. Rivastigmine (oral route) - Side effects & dosage - Mayo Clinic

    For oral dosage forms (capsules or solution):. For treatment of Alzheimer's disease: Adults—At first, 1.5 milligrams (mg) two times a day. Your doctor may ...

  4. An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE - Mayo Clinic

    Study phase. 2/3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase ( ...

  5. SenolyticsTreatment of Interstitial Lung Disease in Common Variable Immunodeficiency - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  6. A Study to Evaluate TAK-018 for Prevention of the Recurrence of Postoperative Crohn's Disease (CD) - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  7. A Study To Evaluate Hyperthermic Intraperitoneal Chemotherapy To Treat Patients With Pancreatic Cancer And Peritoneal Metastasis - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  8. Dose Escalation Study in Patients With Relapsed or Refractory DLBCL and MyD88 L265P Mutation - Mayo Clinic

    Study phase. 1/2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase ( ...

  9. A Study of INCMGA00012 in Metastatic Merkel Cell Carcinoma - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  10. Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer - Mayo Clinic

    Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...